Zafgen Announces FDA Partial Clinical Hold On Obesity Trials
October 16, 2015 at 13:30 PM EDT
Shares of Zafgen are down 32% today after the FDA announced a partial clinical hold on the company's obesity trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.